Urine macrophage migration inhibitory factor in pediatric systemic lupus erythematosus

Clin Rheumatol. 2007 Dec;26(12):2105-2107. doi: 10.1007/s10067-007-0632-z. Epub 2007 May 4.

Abstract

We reported a series of ten patients with lupus nephritis (five patients in the relapse phase and five in the remission phase) and measured the macrophage migration inhibitory factor (MIF), an important pro-inflammatory cytokine with probable role in the pathogenesis of many inflammatory diseases, in their urine samples. MIF/creatinine (Cr) ratio directly correlated with disease activity and it does not have any significant difference between inactive disease and normal ones. We found that the urine MIF/Cr ratio not only differentiates active disease from inactive disease and normal ones but also correlates with the activity indices of renal pathology.

MeSH terms

  • Adolescent
  • Biomarkers / urine
  • Child
  • Disease Progression
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Follow-Up Studies
  • Humans
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / urine*
  • Macrophage Migration-Inhibitory Factors / urine*
  • Male
  • Prognosis
  • Prospective Studies
  • Recurrence
  • Severity of Illness Index

Substances

  • Biomarkers
  • Macrophage Migration-Inhibitory Factors